journal cover

Oral 5-aminosalicylic acid for inducing remission in ulcerative colitis

The Cochrane Database of Systematic Reviews

May 5, 2000

L SutherlandK Makiyama

Abstract

To assess the efficacy, dose-responsiveness and safety of the newer release formulations of 5-aminosalicylic acid (5-ASA) compared to placebo or sulfasalazine (SASP) for the induction of remission in active ulcerative colitis. A computer-assisted literature search for relevant studies (...read more

Mentioned in this Paper

Endoscopy (Procedure)
Remission, Spontaneous
Sulfasalazin medac
Cancer Remission
Mesalamine
TXN protein, human
Remission Induction
Clinical Trial [Publication Type]
ASPRV1 gene
Ulcerative Colitis
Paper Details
References
  • References
  • Citations14
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations14
12

Similar Papers Found In These Feeds

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Related Papers

The Cochrane Database of Systematic Reviews

Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis

The Cochrane Database of Systematic ReviewsMay 5, 2000
L SutherlandK Makiyama
The American Journal of Gastroenterology

5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis

The American Journal of GastroenterologyAugust 19, 2010
Alexander C FordPaul Moayyedi
© 2020 Meta ULC. All rights reserved

Oral 5-aminosalicylic acid for inducing remission in ulcerative colitis

The Cochrane Database of Systematic Reviews

May 5, 2000

L SutherlandK Makiyama

PMID: 10796555

DOI: 10.1002/14651858.cd000543

Abstract

To assess the efficacy, dose-responsiveness and safety of the newer release formulations of 5-aminosalicylic acid (5-ASA) compared to placebo or sulfasalazine (SASP) for the induction of remission in active ulcerative colitis. A computer-assisted literature search for relevant studies (...read more

Mentioned in this Paper

Endoscopy (Procedure)
Remission, Spontaneous
Sulfasalazin medac
Cancer Remission
Mesalamine
TXN protein, human
Remission Induction
Clinical Trial [Publication Type]
ASPRV1 gene
Ulcerative Colitis

Similar Papers Found In These Feeds

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Related Papers

The Cochrane Database of Systematic Reviews

Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis

The Cochrane Database of Systematic ReviewsMay 5, 2000
L SutherlandK Makiyama
The American Journal of Gastroenterology

5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis

The American Journal of GastroenterologyAugust 19, 2010
Alexander C FordPaul Moayyedi
Paper Details
References
  • References
  • Citations14
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations14
12
/papers/oral-5-aminosalicylic-acid-for-inducing-remission/10796555